Comparison of treatment with insulin degludec and glargine U100 in patients with type 1 diabetes prone to nocturnal severe hypoglycaemia: The HypoDeg randomized, controlled, open‐label, crossover trial

AIM: To investigate whether the long‐acting insulin analogue insulin degludec compared with insulin glargine U100 reduces the risk of nocturnal symptomatic hypoglycaemia in patients with type 1 diabetes (T1D). METHODS: Adults with T1D and at least one episode of nocturnal severe hypoglycaemia during...

Descripción completa

Detalles Bibliográficos
Autores principales: Pedersen‐Bjergaard, Ulrik, Agesen, Rikke M., Brøsen, Julie M. B., Alibegovic, Amra C., Andersen, Henrik U., Beck‐Nielsen, Henning, Gustenhoff, Peter, Hansen, Troels K., Hedetoft, Christoffer, Jensen, Tonny J., Juhl, Claus B., Jensen, Andreas K., Lerche, Susanne S., Nørgaard, Kirsten, Parving, Hans‐Henrik, Sørensen, Anne L., Tarnow, Lise, Thorsteinsson, Birger
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2021
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298237/
https://www.ncbi.nlm.nih.gov/pubmed/34643020
http://dx.doi.org/10.1111/dom.14574

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9298237/
https://www.ncbi.nlm.nih.gov/pubmed/34643020
http://dx.doi.org/10.1111/dom.14574

Ejemplares similares